1,755 filings
Page 27 of 88
6-K
8ta3u4zdvdz1 hgd
8 May 15
Teva to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
12:00am
SC TO-T/A
m31wvu9x6gpm1isubytn
5 May 15
Third party tender offer statement (amended)
12:00am
425
qwfde
5 May 15
Business combination disclosure
12:00am
6-K
a501i5ba 24pxdtj61
5 May 15
Teva Provides Additional Detail on Proposed Acquisition of Mylan
12:00am
425
l6q8nj q3pu57a6s93al
5 May 15
Business combination disclosure
12:00am
6-K
fd8 cl3q2ueqg6w0i53
5 May 15
Teva Completes Acquisition of Auspex Pharmaceuticals
12:00am
425
1kl qr4gwo
1 May 15
Business combination disclosure
12:00am
6-K
jvonro9la07lq0kx 6w
30 Apr 15
Teva Reports First Quarter 2015 Results
12:00am
6-K
2uz 73a338xmja6u
30 Apr 15
Current report (foreign)
12:00am
6-K
kssj86
29 Apr 15
Current report (foreign)
12:00am
425
v55e1xi6rth61shuucr
29 Apr 15
Business combination disclosure
12:00am
425
xhm ft7rdjp
29 Apr 15
Business combination disclosure
12:00am
425
92ap wctl
29 Apr 15
Business combination disclosure
12:00am
6-K
3zq5zw
28 Apr 15
Teva Continues to Invigorate Injectable Portfolio with the Launch of Argatroban Injection In the United States
12:00am
6-K
jfna0m5nvljpsbn mk
28 Apr 15
Teva Launches Generic Abilify® Tablets In the United States
12:00am
6-K
8umvvfnf
27 Apr 15
Teva Reiterates Commitment to Cash-and-stock Acquisition
12:00am
425
ombxu
27 Apr 15
Business combination disclosure
12:00am
SC TO-T/A
iwqgmrle
24 Apr 15
Third party tender offer statement (amended)
12:00am
425
zzf37kia
24 Apr 15
Business combination disclosure
12:00am
6-K
hahe73jya
23 Apr 15
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
12:00am